Engineers Gate Manager’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,922
| Closed | -$72.8K | – | 2383 |
|
|
2023
Q4 | $72.8K | Buy |
+13,922
| New | +$72.8K | ﹤0.01% | 1810 |
|
|
2022
Q3 | – | Sell |
-9,767
| Closed | -$434K | – | 2165 |
|
|
2022
Q2 | $434K | Buy |
9,767
+4,448
| +84% | +$198K | 0.02% | 1189 |
|
|
2022
Q1 | $263K | Buy |
+5,319
| New | +$263K | 0.01% | 1486 |
|
|
2021
Q3 | – | Sell |
-10,034
| Closed | -$429K | – | 2048 |
|
|
2021
Q2 | $429K | Sell |
10,034
-7,314
| -42% | -$313K | 0.03% | 923 |
|
|
2021
Q1 | $724K | Buy |
17,348
+564
| +3% | +$23.5K | 0.04% | 754 |
|
|
2020
Q4 | $782K | Sell |
16,784
-10,934
| -39% | -$509K | 0.03% | 711 |
|
|
2020
Q3 | $1.18M | Buy |
27,718
+6,434
| +30% | +$273K | 0.06% | 528 |
|
|
2020
Q2 | $1.02M | Sell |
21,284
-8,501
| -29% | -$408K | 0.05% | 587 |
|
|
2020
Q1 | $1.37M | Buy |
29,785
+20,425
| +218% | +$939K | 0.1% | 294 |
|
|
2019
Q4 | $562K | Sell |
9,360
-10,864
| -54% | -$652K | 0.02% | 936 |
|
|
2019
Q3 | $1.14M | Buy |
+20,224
| New | +$1.14M | 0.06% | 492 |
|
|
2019
Q2 | – | Sell |
-23,459
| Closed | -$1.18M | – | 1421 |
|
|
2019
Q1 | $1.18M | Sell |
23,459
-8,681
| -27% | -$438K | 0.07% | 397 |
|
|
2018
Q4 | $1.3M | Buy |
32,140
+7,345
| +30% | +$296K | 0.1% | 296 |
|
|
2018
Q3 | $1.72M | Buy |
24,795
+860
| +4% | +$59.6K | 0.13% | 250 |
|
|
2018
Q2 | $1.81M | Buy |
+23,935
| New | +$1.81M | 0.14% | 235 |
|
|
2017
Q3 | – | Sell |
-5,632
| Closed | -$444K | – | 848 |
|
|
2017
Q2 | $444K | Buy |
+5,632
| New | +$444K | 0.04% | 526 |
|
|
2017
Q1 | – | Sell |
-9,665
| Closed | -$767K | – | 794 |
|
|
2016
Q4 | $767K | Buy |
+9,665
| New | +$767K | 0.08% | 372 |
|